Literature DB >> 24576496

Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Yvette Dehnes1, Jufang Shan2, Thijs Beuming3, Lei Shi4, Harel Weinstein5, Jonathan A Javitch6.   

Abstract

The dopamine transporter (DAT), a member of the neurotransmitter:sodium symporter family, mediates the reuptake of dopamine at the synaptic cleft. DAT is the primary target for psychostimulants such as cocaine and amphetamine. We previously demonstrated that cocaine binding and dopamine transport alter the accessibility of Cys342 in the third intracellular loop (IL3). To study the conformational changes associated with the functional mechanism of the transporter, we made cysteine substitution mutants, one at a time, from Phe332 to Ser351 in IL3 of the background DAT construct, X7C, in which 7 endogenous cysteines were mutated. The accessibility of the 20 engineered cysteines to polar charged sulfhydryl reagents was studied in the absence and presence of cocaine or dopamine. Of the 11 positions that reacted with methanethiosulfonate ethyl ammonium, as evidenced by inhibition of ligand binding, 5 were protected against this inhibition by cocaine and dopamine (S333C, S334C, N336C, M342C and T349C), indicating that reagent accessibility is affected by conformational changes associated with inhibitor and substrate binding. In some of the cysteine mutants, transport activity is disrupted, but can be rescued by the presence of zinc, most likely because the distribution between inward- and outward-facing conformations is restored by zinc binding. The experimental data were interpreted in the context of molecular models of DAT in both the inward- and outward-facing conformations. Differences in the solvent accessible surface area for individual IL3 residues calculated for these states correlate well with the experimental accessibility data, and suggest that protection by ligand binding results from the stabilization of the outward-facing configuration. Changes in the residue interaction networks observed from the molecular dynamics simulations also revealed the critical roles of several positions during the conformational transitions. We conclude that the IL3 region of DAT undergoes significant conformational changes in transitions necessary for both cocaine binding and substrate transport.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cocaine binding; Cysteine accessibility; Dopamine transport; Dopamine transporter (DAT); Molecular dynamics simulations

Mesh:

Substances:

Year:  2014        PMID: 24576496      PMCID: PMC4058377          DOI: 10.1016/j.neuint.2014.02.003

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  50 in total

Review 1.  Plasma membrane monoamine transporters: structure, regulation and function.

Authors:  Gonzalo E Torres; Raul R Gainetdinov; Marc G Caron
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

2.  Generation of an activating Zn(2+) switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle.

Authors:  Claus Juul Loland; Lene Norregaard; Thomas Litman; Ulrik Gether
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Substituted-cysteine accessibility method.

Authors:  A Karlin; M H Akabas
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

5.  Mechanism of action of methylphenidate: insights from PET imaging studies.

Authors:  N D Volkow; J S Fowler; G Wang; Y Ding; S J Gatley
Journal:  J Atten Disord       Date:  2002       Impact factor: 3.256

6.  Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment.

Authors:  H Hastrup; A Karlin; J A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

7.  [3H]MFZ 2-12: a novel radioligand for the dopamine transporter.

Authors:  A H Newman; M F Zou; J V Ferrer; J A Javitch
Journal:  Bioorg Med Chem Lett       Date:  2001-07-09       Impact factor: 2.823

8.  Defining proximity relationships in the tertiary structure of the dopamine transporter. Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn(2+)-binding site.

Authors:  C J Loland; L Norregaard; U Gether
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.

Authors:  Claus Juul Loland; Charlotta Grånäs; Jonathan A Javitch; Ulrik Gether
Journal:  J Biol Chem       Date:  2003-11-03       Impact factor: 5.157

10.  Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I.

Authors:  L Keith Henry; Erika M Adkins; Qiao Han; Randy D Blakely
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

View more
  8 in total

1.  Neurotransmitter and psychostimulant recognition by the dopamine transporter.

Authors:  Kevin H Wang; Aravind Penmatsa; Eric Gouaux
Journal:  Nature       Date:  2015-05-11       Impact factor: 49.962

2.  Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Authors:  Amy E Moritz; Danielle E Rastedt; Daniel J Stanislowski; Madhur Shetty; Margaret A Smith; Roxanne A Vaughan; James D Foster
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

3.  Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.

Authors:  Sathya Challasivakanaka; Juan Zhen; Margaret E Smith; Maarten E A Reith; James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2017-09-22       Impact factor: 5.157

Review 4.  Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

5.  Insights into the Modulation of Dopamine Transporter Function by Amphetamine, Orphenadrine, and Cocaine Binding.

Authors:  Mary Hongying Cheng; Ethan Block; Feizhuo Hu; Murat Can Cobanoglu; Alexander Sorkin; Ivet Bahar
Journal:  Front Neurol       Date:  2015-06-09       Impact factor: 4.003

6.  Targeting of dopamine transporter to filopodia requires an outward-facing conformation of the transporter.

Authors:  Shiqi Ma; Mary H Cheng; Daryl A Guthrie; Amy H Newman; Ivet Bahar; Alexander Sorkin
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

Review 7.  Monoamine transporters: insights from molecular dynamics simulations.

Authors:  Julie Grouleff; Lucy Kate Ladefoged; Heidi Koldsø; Birgit Schiøtt
Journal:  Front Pharmacol       Date:  2015-10-16       Impact factor: 5.810

8.  Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter-In Silico and In Vitro Exploration of Dissociative Diarylethylamines.

Authors:  Michelle A Sahai; Colin Davidson; Neelakshi Dutta; Jolanta Opacka-Juffry
Journal:  Brain Sci       Date:  2018-04-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.